Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
06/2000
06/15/2000WO2000034521A1 Methods, kits and compositions for the identification of nucleic acids electrostatically bound to matrices
06/15/2000WO2000034520A1 Genetic markers which identify individuals who improve their cholesterol levels and diabetes status with exercise
06/15/2000WO2000034519A1 Blocked-polymerase polynucleotide immunoassay method and kit
06/15/2000WO2000034518A1 Array and method for analysing nucleic acid sequences
06/15/2000WO2000034517A1 Detection of mycobacterium avium subspecies
06/15/2000WO2000034516A1 Detection of rantes gene promotor polymorphisms
06/15/2000WO2000034515A1 Use of factor x polymorphism in the diagnosis and treatment of factor x and/or factor xa mediated diseases
06/15/2000WO2000034514A1 METHOD FOR DETERMINING THE ACTIVITY OF A SUBSTANCE USING A FUNCTIONAL TEST $i(IN VITRO)
06/15/2000WO2000034513A1 METHOD FOR DETECTING IN VITRO A TARGET SUBSTANCE IN A SAMPLE COMPRISING THE LABELLING OF SAID SUBSTANCE WITH A REPORTER GENE AND THE SEQUENCES REQUIRED FOR EXPRESSING SAID REPORTER GENE $i(IN VITRO)
06/15/2000WO2000034512A1 Method for detecting and/or quantifying a known function from a nucleic acid sample
06/15/2000WO2000034511A2 Aβ-PEPTIDE SCREENING ASSAY
06/15/2000WO2000034510A1 Method for purifying or isolating viral nucleic acids
06/15/2000WO2000034508A1 Method for detecting micro-organisms and support used in said method
06/15/2000WO2000034507A1 A method of isolating stem cells
06/15/2000WO2000034506A2 Method of screening candidate compounds for susceptibility to oxidative metabolism
06/15/2000WO2000034494A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000WO2000034486A1 Human secretory phospholipase a¿2?
06/15/2000WO2000034485A2 Beta-1,3-galactosyltransferase homologs
06/15/2000WO2000034484A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains
06/15/2000WO2000034483A2 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000WO2000034481A2 DRUG TARGETS IN $i(CANDIDA ALBICANS)
06/15/2000WO2000034477A2 Neuron-associated proteins
06/15/2000WO2000034474A2 Growth factor homolog zvegf3
06/15/2000WO2000034466A1 Cervical cancer treatment
06/15/2000WO2000034464A1 Method for yeast screening of protein-kinase modulators specific of superior eukaryotic cells, including human cells
06/15/2000WO2000034463A1 Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis
06/15/2000WO2000034457A1 Method for immobilizing oligonucleotide on a carrier
06/15/2000WO2000034456A1 Method for immobilizing dna on a carrier
06/15/2000WO2000034450A1 Cutinase variants
06/15/2000WO2000034449A2 UDP-N- ACETYL GLUCOSAMINE: GALACTOSE-β1, 3-N- ACETYL GALACTOSAMINE- α-R/ N- ACETYL GLUCOSAMINE -β1, 3-N- ACETYL GALACTOSAMINE- α-R (GlcNAc TO GalNAc) β1,6-N- ACETYL GLUCOSAMINYL TRANSFERASE, C2/4GnT
06/15/2000WO2000034447A2 Human ubiquitin ligase e3 for the modulation of nf-kappa b
06/15/2000WO2000034439A1 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
06/15/2000WO2000034438A2 Method for constructing libraries of phenotypic profiles
06/15/2000WO2000034334A1 DNA ENCODING A MAMMALIAN RECEPTOR (fb41a) AND USES THEREOF
06/15/2000WO2000034330A1 Cark protein and nucleic acid molecules and uses therefor
06/15/2000WO2000034327A1 Mammalian sulphatases and genetic sequences encoding same
06/15/2000WO2000034308A2 Protein transduction system and methods of use thereof
06/15/2000WO2000034294A2 Tumor necrosis factor receptor homologue-1 ('trh1')
06/15/2000WO2000033872A2 Method of and compositions for immunization with the pseudomonas v antigen
06/15/2000WO2000033841A1 Myt1 kinase inhibitors
06/15/2000WO2000033826A1 Anticancer agents based on prevention of protein prenylation
06/15/2000WO2000033635A2 Primer-independent rna synthesis catalyzed by hcv polymerase
06/15/2000WO2000023618A8 Polymorphism in a tgf-beta gene correlated to osteoporosis
06/15/2000WO2000012678A3 Staphylococcus aureus genes and polypeptides
06/15/2000WO2000009740A3 Method and apparatus for detecting viruses using primary and secondary biomarkers
06/15/2000WO2000009693A3 Identification of the gene causing the mouse scurfy phenotype and its human ortholog
06/15/2000WO2000009654A3 Profiling and cataloging expressed protein tags
06/15/2000WO2000008178A3 Murine dna molecules encoding polypeptides having kinase functions
06/15/2000WO2000006718A3 Expression of functional eukaryotic proteins
06/15/2000WO2000005374A3 Molecules associated with cell proliferation
06/15/2000WO2000005366A3 Xiap ires and uses thereof
06/15/2000WO2000001846A3 Characterisation of gene function using double stranded rna inhibition
06/15/2000WO2000001821A3 Neurotransmission associated proteins
06/15/2000WO1999066051A3 Nek-related and bub1-related protein kinases
06/15/2000WO1999061452A3 acpS
06/15/2000WO1999014328A3 Secreted and transmembrane polypeptides and nucleic acids encoding the same
06/15/2000DE19921940A1 Verfahren zur elektrochemischen Detektion von Nukleinsäureoligomerhybriden Process for the electrochemical detection of Nukleinsäureoligomerhybriden
06/15/2000DE19857619A1 Screening for inhibitors of the terpenoid biosynthetic pathway that may be used as herbicides
06/15/2000DE19856928A1 Enzymatic preparation of mangan ions, superoxide anions and hydrogen peroxide uses laccase
06/15/2000DE19856415A1 Verfahren zur Reinigung bzw. Isolierung viraler Nukleinsäuren Methods for cleaning or isolation of viral nucleic acids
06/15/2000DE19855469A1 Verfahren zur Bestimmung des Apolipoprotein-E-Genotyps in einer menschlichen Probe Method for determining the apolipoprotein E genotype of a human sample in
06/15/2000DE19844931C1 Verfahren zur DNS- oder RNS-Sequenzierung A method for DNA or RNA sequencing
06/15/2000CA2791961A1 Desaturases and methods of using them for synthesis of polyunsaturated fatty acids
06/15/2000CA2746535A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000CA2678259A1 A recombinant vector expressing multiple costimulatory molecules and uses thereof
06/15/2000CA2354986A1 Method for detecting in vitro a target substance in a sample comprising the labelling of said substance with a reporter gene and the sequences required for expressing said reporter gene in vitro
06/15/2000CA2354673A1 Method for determining asthma susceptibility
06/15/2000CA2354612A1 Tumor necrosis factor receptor homologue-1 ("trh1")
06/15/2000CA2354610A1 Human secretory phospholipase a2
06/15/2000CA2354572A1 Method for determining the activity of a substance using a functional test in vitro
06/15/2000CA2354322A1 Methods of identifying point mutations in a genome
06/15/2000CA2354232A1 Compounds and methods for treatment and diagnosis of chlamydial infection
06/15/2000CA2354150A1 Detection of rantes gene promotor polymorphisms
06/15/2000CA2354084A1 Methods for detection of antiestrogen-resistant breast cancer
06/15/2000CA2354044A1 Protein transduction system and methods of use thereof
06/15/2000CA2354026A1 Beta-1,3-galactosyltransferase homologs
06/15/2000CA2353867A1 Anticancer agents based on prevention of protein prenylation
06/15/2000CA2353797A1 Neuron-associated proteins
06/15/2000CA2353773A1 Cark protein and nucleic acid molecules and uses therefor
06/15/2000CA2353701A1 Method for detecting the presence of stem cells utilizing a detectable substrate for aldehyde dehydrogenase (aldh)
06/15/2000CA2353616A1 Assays for compounds which increase phospholipase a2 activity
06/15/2000CA2353580A1 Detection of mycobacterium avium subspecies
06/15/2000CA2353525A1 Drug targets in candida albicans
06/15/2000CA2353309A1 Toxicity typing using embryoid bodies
06/15/2000CA2352877A1 Interface patch clamping
06/15/2000CA2352534A1 Polymorphic loci that differentiate escherichia coli 0157:h7 from other strains
06/15/2000CA2352523A1 Method of screening candidate compounds for susceptibility to oxidative metabolism
06/15/2000CA2352481A1 Method for detecting micro-organisms and support used in said method
06/15/2000CA2352476A1 Array and method for analysing nucleic acid sequences
06/15/2000CA2352472A1 Formulations and methods for isolating nucleic acids from any complex starting material and subsequent complex genetic analysis
06/14/2000EP1008853A2 Reagent compositions for measuring electrolyte using alpha-amylase
06/14/2000EP1008845A1 Apparatus and method for standing wave microscopy, also for DNA sequencing, and calibration procedure
06/14/2000EP1008658A1 Solid phase for detecting nucleic acid and method for detecting nucleic acid
06/14/2000EP1008657A2 Method and reagent for quantitative determination of 1,5-anhydroglucitol
06/14/2000EP1008650A1 Novel mapk kinase
06/14/2000EP1008648A1 Gene causative of rheumatoid arthritis, method for the diagnosis of rheumatoid arthritis, and method for the determination of factors causing rheumatoid arthritis
06/14/2000EP1008600A2 Compositions and methods for generating red chemiluminescence
06/14/2000EP1008242A2 Use of shp-1 and shp-2 to detect compounds involved in neuronal survival
06/14/2000EP1008098A1 Method for remote sensing analysis by decorrelation statistical analysis and hardware therefor
06/14/2000EP1007969A1 Lithographic mask design and synthesis of diverse probes on a substrate